Rotarix vaccine oral syringe 1.5ML
Ended Awarded
- Contract number
- SPE2DB25FGXQB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,066
Award facts
- Contract value 100% obligated
- $14,065.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Rotarix Vaccine Oral Syringe 1.5ML with a ceiling value of $14,065.80. This firm fixed price delivery order, which is expected to be completed by August 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's broader IDC vehicle with DLA enables the supply of a comprehensive range of pharmaceutical products and medical supplies, including vaccines, medications, syringes, and specialized medical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. This delivery order for the oral rotavirus vaccine reflects AmerisourceBergen's role in supporting immunization programs within the federal healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB25FGXQB?
SPE2DB25FGXQB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FGXQB worth?
The government has obligated $14,066 on SPE2DB25FGXQB.
Is contract SPE2DB25FGXQB an order under another contract?
Yes. SPE2DB25FGXQB is a delivery order under SPE2DB24D2213, an indefinite delivery contract.
Was contract SPE2DB25FGXQB competed?
The extent of competition for SPE2DB25FGXQB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award